TrialBreast cancer research and treatment2014

A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102.

Julie R Gralow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.